Intrathecal drug administration via lumbar puncture and a spinal access port device led to serious complications in a patient receiving experimental therapy for Niemann-Pick type C. In a case report ...

Objectives: To report insidious development of autonomic dysreflexia and hydronephrosis due to dyssynergic voiding following discontinuation of intrathecal baclofen therapy. Setting: Regional Spinal ...

Chemotherapy medications can come in many forms and types (oral, injectable, inhaled, etc.). If you need medication, the type that’s right for you will depend on how the medication works and the ...

Please provide your email address to receive an email when new articles are posted on . Early intrathecal therapy effectively resolved symptoms related to high-grade neurotoxicity among patients who ...

A novel indwelling subcutaneous intrathecal catheter circumvented the complex spine anatomy of patients with spinal muscular atrophy (SMA), a challenge when giving nusinersen via intrathecal injection ...

PALM SPRINGS, CA—Small, sophisticated, reliable, and controllable implantable pumps, ongoing research, and clinical consensus with respect to the safe delivery of intrathecal medications for chronic ...

DUBAI, United Arab Emirates — Intrathecal interferon-α2B (IT-IFN) appears to be a safe and efficacious treatment option for patients with subacute sclerosing panencephalitis (SSPE), a devastating, ...

In a recent study published in Nanomedicine: Nanotechnology, Biology and Medicine, researchers evaluated the biodistribution of cannabidiol (CBD) emulsion and nanoparticles in the central nervous ...

Long-Term Incidence and Predictors of Significant Hearing Loss Requiring Hearing Assistive Devices Among Childhood Cancer Survivors: A Population-Based Study Postinduction CNS prophylaxis with ITT did ...

Phase I study of vorinostat (suberoylanilide hydroxamic acid) in combination with temozolomide (TMZ) in patients with malignant gliomas (NABTC 04–03) No significant financial relationships to disclose ...

A study presented at the American Academy of Pain Medicine’s 26th annual meeting investigated methods for reducing the estimated $1 billion spent annually on pain care treatment in the United States ...